Attacking cancer's weaknesses, with Dr. Alan Ashworth

24:07
 
Share
 

Manage episode 213994498 series 2360010
By BCRF. Discovered by Player FM and our community — copyright is owned by the publisher, not Player FM, and audio is streamed directly from their servers. Hit the Subscribe button to track updates in Player FM, or paste the feed URL into other podcast apps.
It sounds like something out of Game of Thrones: Attack the weakness. Today, we apply the phrase to a more important and real battle – the one against breast cancer.As you’ll hear, Dr. Alan Ashworth is part of a team that developed something called PARP Inhibitors and, quite creatively, identified ways to use them to attack the weaknesses of various cancers, including breast cancer. As a recent new report noted, “with three recent FDA approvals, and a number of Phase 3 trials ongoing, the drugs are seeing a surge in interest.”How do PARP Inhibitors work and what might they mean for attacking cancers’ weaknesses?That’s just part of what I discussed with Dr. Ashworth. Some background: He’s the President, UCSF Helen Diller Family Comprehensive Cancer Center; Senior Vice President for Cancer Services of UCSF Health; and a Professor in the Division of Hematology/Oncology at UCSF’s Department of Medicine. Dr. Ashworth is an elected member of EMBO, the Academy of Medical Sciences, and a Fellow of the Royal Society. He has won a number of the world’s leading scientific prizes and awards, and he’s also a BCRF Investigator since 2008.

34 episodes